The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Activation of CYP3A4: Evidence for the Simultaneous Binding of Two Substrates in a Cytochrome P450 Active Site
Abstract
A unique characteristic of the CYP3A subfamily of cytochrome P450 enzymes is their ability to be activated by certain compounds. It is reported that CYP3A4-catalyzed phenanthrene metabolism is activated by 7,8-benzoflavone and that 7,8-benzoflavone serves as a substrate for CYP3A4. Kinetic analyses of these two substrates show that 7,8-benzoflavone increases the Vmax of phenanthrene metabolism without changing the Km and that phenanthrene decreases the Vmax of 7,8-benzoflavone metabolism without increasing the Km. These results suggest that both substrates (or substrate and activator) are simultaneously present in the active site. Both compounds must have access to the active oxygen, since neither phenanthrene nor 7,8-benzoflavone can competitively inhibit the other substrate. These data provide the first evidence that two different molecules can be simultaneously bound to the same P450 active site. Additionally, structure-activity relationship studies were performed with derivatives of 7,8-benzoflavone structure. The effects of 13 different compounds on the regioselectivity of phenanthrene, chrysene, and benzo[a]pyrene metabolism were determined. Of the 13 compounds studied, 6 were activators, 2 were partial activators, and 5 were inhibitors. Analyses of the data suggest that (1) naphthalene substituted with a ketone in the 2-position can activate 3A4 and (2) the presence of an activator results in a narrower effective substrate binding site. Since the CYP3A enzymes are very important in drug metabolism, the possibility of activation, and autoactivation, must be considered when in vitro-in vivo correlations are made and when possible drug interactions are considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dewar, M. J. S., Zoebisch, E. G., Healy, E. F., & Stewart, J. J. P. (1985) · Journal of the American Chemical Society · doi:10.1021/ja00299a024 · Cited by 13,074
The Carbon Monoxide-binding Pigment of Liver Microsomes
Omura, T., & Sato, R. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82244-3 · Cited by 11,781
[6] Statistical analysis of enzyme kinetic data
Wallace Cleland, W. (1979) · Methods in Enzymology · doi:10.1016/0076-6879(79)63008-2 · Cited by 1,984
The P450 Superfamily: Update on New Sequences, Gene Mapping, and Recommended Nomenclature
NEBERT, D. W., NELSON, D. R., COON, M. J., ESTABROOK, R. W., FEYEREISEN, R., FUJII-KURIYAMA, Y., GONZALEZ, F. J., GUENGERICH, F. P., GUNSALUS, I. C., JOHNSON, E. F., et al. (1991) · DNA and Cell Biology · doi:10.1089/dna.1991.10.1 · Cited by 1,094
Self-citationAoyama, T., Yamano, S., Waxman, D. J., Lapenson, D. P., Meyer, U. A., Fischer, V, Tyndale, R., Inaba, T., Kalow, W., Gelboin, H. V., et al. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81632-5 · Cited by 482
Self-citationTHE OXIDATION OF DRUGS BY LIVER MICROSOMES: ON THE ROLE OF TPNH AND OXYGEN
Gillette, J. H., Brodie, B. B., & La Du, B. N. (1957) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11915-0 · Cited by 407
Wiebel, F. J., Leutz, J. C., Diamond, L., & Gelboin, H. V. (1971) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(71)90456-5 · Cited by 369
Self-citationGorsky, L. D., Koop, D. R., & Coon, M. J. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39800-9 · Cited by 329
Wrighton, S. A., Maurel, P., Schuetz, E. G., Watkins, P. B., Young, B., & Guzelian, P. S. (1985) · Biochemistry · doi:10.1021/bi00330a010 · Cited by 299
Raag, R., & Poulos, T. L. (1991) · Biochemistry · doi:10.1021/bi00224a016 · Cited by 210
Cited by
Cytochrome P450 and Chemical Toxicology
Guengerich, F. P. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700079z · Cited by 1,725
CYTOCHROME P-450 3A4: Regulation and Role in Drug Metabolism
Guengerich, F. P. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.1 · Cited by 1,267
IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A
Thummel, K. E., & Wilkinson, G. R. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.389 · Cited by 831
Summary of information on human CYP enzymes: human P450 metabolism data
Rendic, S. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001392 · Cited by 820
Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone
Williams, P. A., Cosme, J., Vinković, D. M., Ward, A., Angove, H. C., Day, P. J., Vonrhein, C., Tickle, I. J., & Jhoti, H. (2004) · Science · doi:10.1126/science.1099736 · Cited by 806
Guengerich, F. P. (1995) · Cytochrome P450 · doi:10.1007/978-1-4757-2391-5_14 · Cited by 728
Role of Pharmacokinetics and Metabolism in Drug Discovery and Development
Lin, J. H., & Lu, A. Y. H. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01340-1 · Cited by 708
Yano, J. K., Wester, M. R., Schoch, G. A., Griffin, K. J., Stout, C. D., & Johnson, E. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400293200 · Cited by 705
The Gut as a Barrier to Drug Absorption: Combined Role of Cytochrome P450 3A and P-Glycoprotein
Zhang, Y., & Benet, L. Z. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140030-00002 · Cited by 518
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
Zhou, S., Yung Chan, S., Cher Goh, B., Chan, E., Duan, W., Huang, M., & McLeod, H. L. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544030-00005 · Cited by 517
Korzekwa, K. R., Krishnamachary, N., Shou, M., Ogai, A., Parise, R. A., Rettie, A. E., Gonzalez, F. J., & Tracy, T. S. (1998) · Biochemistry · doi:10.1021/bi9715627 · Cited by 511
Self-citationSynergistic Activation of Estrogen Receptor with Combinations of Environmental Chemicals
Arnold, S. F., Klotz, D. M., Collins, B. M., Vonier, P. M., Guillette, L. J., & McLachlan, J. A. (1996) · Science · doi:10.1126/science.272.5267.1489 · Cited by 499
RetractedHouston, J. B., & Kenworthy, K. E. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15358-5 · Cited by 389
Methadone—metabolism, pharmacokinetics and interactions
FERRARI, A., COCCIA, C., BERTOLINI, A., & STERNIERI, E. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2004.05.002 · Cited by 384
Recent Structural Insights into Cytochrome P450 Function
Guengerich, F. P., Waterman, M. R., & Egli, M. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.05.006 · Cited by 383
Oestrogenic activity of parabens in MCF7 human breast cancer cells
Byford, J. R., Shaw, L. E., Drew, M. G. B., Pope, G. S., Sauer, M. J., & Darbre, P. D. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00174-1 · Cited by 361
Inhibition and induction of human cytochrome P450 (CYP) enzymes
PELKONEN, O., MÄEENPÄEÄ, J., TAAVITSAINEN, P., RAUTIO, A., & RAUNIO, H. (1998) · Xenobiotica · doi:10.1080/004982598238886 · Cited by 358
Faucette, S. R., Hawke, R. L., Lecluyse, E. L., Shord, S. S., Yan, B., Laethem, R. M., & Lindley, C. M. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0026-895x(24)12054-8 · Cited by 353
CYP3A4 drug interactions: correlation of 10 in vitro probe substrates
Kenworthy, Bloomer, Clarke, & Houston (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00073.x · Cited by 336
Differential Metabolism of Gefitinib and Erlotinib by Human Cytochrome P450 Enzymes
Li, J., Zhao, M., He, P., Hidalgo, M., & Baker, S. D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0088 · Cited by 311
Human Drug Metabolism and the Cytochromes P450: Application and Relevance of In Vitro Models
Venkatakrishnan, K., von Moltke, L. L., & Greenblatt, D. J. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122012724 · Cited by 308
The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates
Cotreau, M. M., von Moltke, L. L., & Greenblatt, D. J. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00002 · Cited by 292
Patki, K. C., von Moltke, L. L., & Greenblatt, D. J. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.7.938 · Cited by 263
Atypical Kinetic Profiles in Drug Metabolism Reactions
Hutzler, J. M., & Tracy, T. S. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.4.355 · Cited by 261
Yamazaki, H., Johnson, W. W., Ueng, Y.-F., Shimada, T., & Guengerich, F. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27438 · Cited by 194
Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450
Sai, Y., Dai, R., Yang, T. J., Krausz, K. W., Gonzalez, F. J., Gelboin, H. V., & Shou, M. (2000) · Xenobiotica · doi:10.1080/004982500237541 · Cited by 138
Self-citation(1997) · PubMed · Cited by 121
Metadata
- Authors
- Shou, M., Grogan, J., Mancewicz, J. A., Krausz, K. W., Gonzalez, F. J., Gelboin, H. V., & Korzekwa, K. R.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1994-05-01
- Volume
- 33
- Issue
- 21
- Pages
- 6450-6455
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2049770869
- Cited by
- 351
- References
- 19
- FWCI
- 13.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.